Removal of bacteria from the blood by means of extracorporeal techniques has been attempted for decades. In late 2019, the European Union licensed the first ever haemoperfusion device for removal of bacteria from the blood. The active ingredient of Seraph 100 Microbind Affinity Blood Filter is ultrahigh molecular weight polyethylene beads with endpoint-attached heparin. Bacteria have been shown to bind to heparin as they would usually do to the heparan sulfate on the cell surface, thereby being removed from the blood stream. We describe the first case of a female chronic haemodialysis patient in which this device was clinically used for a infection that persisted for 4 days despite antibiotic therapy. After a single treatment, the bacterial load decreased and the blood cultures at the end of a 4 hour haemoperfusion exhibited no bacterial growth.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449289 | PMC |
| http://dx.doi.org/10.1136/bcr-2020-235262 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparison of CytoSorb and Jafron HA330 Hemoadsorption Devices in Pediatric Oncological Patients with Sepsis: Retrospective Observational Study.
J Clin Med
December 2024
Pediatric Anesthesiology and Intensive Care Unit, Mother and Child Center, "University Medical Center", Astana Z05K4F4, Kazakhstan.
Pediatric sepsis presents a severe risk to immunocompromised children, especially those with cancer or pre-existing conditions, posing a significant threat to their lives. Cytokine hemadsorption has emerged as a promising therapeutic approach for managing sepsis and severe inflammatory conditions in critically ill patients. This innovative method involves eliminating pro-inflammatory cytokines from the bloodstream, targeting the underlying hyper-inflammatory response often seen in critical illnesses.
View Article and Find Full Text PDFHemadsorption with CytoSorb in Infants with Sepsis: Non-Systematic Review of Cases.
J Clin Med
November 2024
Department of Surgery, School of Medicine, Nazarbayev University, Astana Z05K4F4, Kazakhstan.
Sepsis is a severe and potentially life-threatening condition that occurs when the body's response to an infection damages its own tissues and organs. It can lead to organ failure and death if not treated. Cytosorb is a promising medical device for hemadsorption in pediatric septic patients (under 18 years old).
View Article and Find Full Text PDFHigh adsorption capacity of hemoperfusion on imipenem in critically ill patients with septic shock: a case report.
BMC Infect Dis
August 2024
Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, China.
Article Synopsis
- Sepsis is a serious condition where the body's response to infection causes organ dysfunction, and hemoperfusion is being used to filter out harmful inflammatory cytokines from the blood.
- In a case study, a 69-year-old man with diabetes developed Multiple Organ Dysfunction Syndrome suspected to be due to septic shock, requiring intensive treatment including broad-spectrum antibiotics and hemoperfusion.
- The treatment showed that hemoperfusion significantly reduced the levels of the antibiotic imipenem in the bloodstream, highlighting the need for additional doses before the procedure to ensure effective antibiotic therapy.
The Seraph 100 Microbind Affinity Blood Filter Does Not Alter Levels of Circulating or Mucosal Antibodies in Critical COVID-19 Patients.
Antibodies (Basel)
August 2024
Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
PURIFY-OBS-1 is an observational study evaluating the safety and efficacy of Seraph 100 Microbind Affinity Blood Filter (Seraph 100) use for COVID-19 patients with respiratory failure admitted to the intensive care unit (ICU). The Seraph 100 is a hemoperfusion device containing heparin-coated beads that can bind to, and reduce levels of, some circulating pathogens and inflammatory molecules. This study evaluated whether treatment with the Seraph 100 affected circulating and mucosal antibody levels in critically ill COVID-19 subjects.
View Article and Find Full Text PDF[Application of Modified Polyether Sulfone Microspheres in Hyperbilirubinemia].
Sichuan Da Xue Xue Bao Yi Xue Ban
July 2024
（ 610041） Department of Nephrology, West China Hospital, Sichuan University, Chengdu 610041, China.
Objective: To design and prepare a high efficiency bilirubin adsorbent with good mechanical properties and biocompatibility.
Methods: In this study, quaternary ammonium pyridine was designed and synthesized, and then modified polyether sulfone microspheres, or PES/p(4-VP-co-N-VP)@6 microspheres, were prepared by phase conversion and electrostatic spraying. The morphology of the polymer components and the microspheres were studied by means of nuclear magnetic resonance (NMR) spectroscopy and scanning electron microscopy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!